Literature DB >> 15272853

Efficient 3D database screening for novel HIV-1 IN inhibitors.

Maria Letizia Barreca1, Angela Rao, Laura De Luca, Maria Zappalà, Cristina Gurnari, Pietro Monforte, Erik De Clercq, Bénédicte Van Maele, Zeger Debyser, Myriam Witvrouw, James M Briggs, Alba Chimirri.   

Abstract

We describe the use of pharmacophore modeling as an efficient tool in the discovery of novel HIV-1 integrase (IN) inhibitors. A three-dimensional hypothetical model for the binding of diketo acid analogues to the enzyme was built by means of the Catalyst program. Using these models as a query for virtual screening, we found several compounds that contain the specified 3D patterns of chemical functions. Biological testing shows that our strategy was successful in searching for new structural leads as HIV-1 IN inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272853     DOI: 10.1021/ci034296e

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  4 in total

Review 1.  Computer tools in the discovery of HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

2.  Computational design of a full-length model of HIV-1 integrase: modeling of new inhibitors and comparison of their calculated binding energies with those previously studied.

Authors:  Selami Ercan; Necmettin Pirinccioglu
Journal:  J Mol Model       Date:  2013-08-02       Impact factor: 1.810

3.  Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA).

Authors:  Devendra K Dhaked; Jitender Verma; Anil Saran; Evans C Coutinho
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

4.  Experimental and theoretical studies on the synthesis of 1,4,5-trisubstituted pyrrolidine-2,3-diones.

Authors:  Nguyen Tran Nguyen; Vo Viet Dai; Nguyen Ngoc Tri; Luc Van Meervelt; Nguyen Tien Trung; Wim Dehaen
Journal:  Beilstein J Org Chem       Date:  2022-08-31       Impact factor: 2.544

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.